At the same time, the elevation of IL-17 and IL-18 in SLE patients may trigger the inflammatory process, and an increase in the IL-18/IL-4 ratio and mRNA levels of IFN-γ/IL-4 (60) tilts the cytokine profile toward inflammatory cascades (53). This evidence concerns the gene IL17A and systemic lupus erythematosus.